Compare · CJC-1295 + Ipamorelin vs BPC-157
CJC-1295 + Ipamorelin vs BPC-157
Researchers frequently look up CJC-1295 + Ipamorelin and BPC-157 side by side. This reference compares the two as laboratory research materials, covering their chemistry, reported molecular targets, and the study areas each appears in. It does not rank them and makes no claim that either is preferable for any purpose; both are supplied strictly for research use.
At a glance
CJC-1295 + Ipamorelin is paired research peptides studied mainly in the context of growth-hormone-axis research and GH / IGF-1 secretion studies. BPC-157 is research peptide associated with tissue-repair models and gut-integrity research.
They sit in different research categories (CJC-1295 + Ipamorelin in Performance & Longevity, BPC-157 in Recovery & Healing), so they tend to appear in distinct bodies of literature.
CJC-1295 + Ipamorelin: chemistry & targets
CJC-1295 No DAC + Ipamorelin is characterized in the literature by GHRH receptor (CJC-1295) and ghrelin / GHS-R1a receptor (Ipamorelin).
- Class
- paired research peptides
- Category
- Performance & Longevity
- Molecular weight
- 3367.97 g/mol (CJC-1295 No DAC) · 711.85 g/mol (Ipamorelin)
- CAS number
- 863288-34-0 (CJC-1295) · 170851-70-4 (Ipamorelin)
- Primary target
- GHRH receptor (CJC-1295)
- Physical form
- Two separate lyophilized vials
BPC-157: chemistry & targets
Body Protection Compound 157 (BPC-157) is characterized in the literature by nitric-oxide (eNOS) signaling, VEGFR2-mediated angiogenesis, and FAK–paxillin cytoskeletal signaling.
- Class
- research peptide
- Category
- Recovery & Healing
- Molecular weight
- 1419.55 g/mol
- CAS number
- 137525-51-0
- Primary target
- nitric-oxide (eNOS) signaling
- Physical form
- Lyophilized powder
How researchers choose between them
Selection in a research setting comes down to the model system and the question being asked: which molecular target is under study, which assays are planned, and how the compound is handled and reconstituted. This is a matter of experimental design, not of one compound being "better."
Both CJC-1295 + Ipamorelin and BPC-157 are available from Blueprint Labs as third-party-tested research materials with certificates of analysis. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Available from Blueprint Labs
CJC 1295 No DAC + IPA 10mg
Both compounds are available from Blueprint Labs as third-party-tested research materials. CJC-1295 + Ipamorelin shown.
Questions, answered
What's the difference between CJC-1295 + Ipamorelin and BPC-157?
They differ in chemistry and reported molecular targets: CJC-1295 + Ipamorelin is associated with GHRH receptor (CJC-1295), while BPC-157 is associated with nitric-oxide (eNOS) signaling. This page compares them only as research materials.
Are CJC-1295 + Ipamorelin and BPC-157 studied together?
They belong to different research categories and generally appear in separate literature. This comparison is for reference only.
Which one is better?
Neither is "better." They are distinct research compounds with different targets, and this reference makes no efficacy, safety, or suitability claim. For research use only. Not for human consumption, diagnostic, or therapeutic use.